Transcatheter mitral valve replacement: patient selection and hemodynamic stability

Heart 2 Heart Conversation - Left Main PCI with Intracoronary Imaging Guidance

Perspectives on drug coated balloons from EuroPCR 2024

ABCs on how to decrease radiation exposure - EuroPCR 2023

When should we perform PCI for stable CAD in aortic stenosis: pre, post, never? - EuroPCR 2023

Is the invasive treatment of pulmonary embolism ready for primetime? - EuroPCR 2023

Why should we consider Bioprosthetic Valve Dysfunction for aortic valve selection?

When to use drug-coated balloons in de novo lesions? - EuroPCR 2023

Multivessel disease: which patients for PCI, CABG or medical treatment? - EuroPCR 2023

What are the indications for PFO closure in 2023? - EuroPCR 2023

What is the role of intra-coronary physiology in guiding complete revascularisation? EuroPCR 2023

EuroPCR 2023 Industry Partner Interview: Edwards Lifesciences

DEFINE FLAIR 5-year and Reveal iFR: learnings on coronary physiology - EuroPCR 2023

CorFlow MOCA I Trial: FIH direct measurement of MVO in STEMI - EuroPCR 2023

New developments in intravascular lithotripsy after 5 years of clinical practice - EuroPCR 2023

Latest evidence and experiences on ultra-thin strut stenting - EuroPCR 2023

Ultra-thin strut stenting to manage challenges in STEMI - EuroPCR 2023

How to support the equal advancement of women in interventional cardiology - EuroPCR 2023

Modern management of PCI in complex lesions - EuroPCR 2023

Results from the DCR4Contrast (Dynamic Coronary Roadmap for Contrast reduction) Trial - EuroPCR 2023

Latest CoreValve Evolut platform’s clinical evidence: impact on current TAVI practice - EuroPCR 2023

Learnings and perspectives from the Asian STEMI Registry - EuroPCR 2023

What does TRILUMINATE Pivotal mean for my patients? - EuroPCR 2023

Intravascular lithotripsy in the real world: the revolution continues - EuroPCR 2023

Learnings and perspectives from the COAPT trial, 5-year follow-up - EuroPCR 2023